Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general

Cesare Cuspidi1, Rita Facchetti, Michele Bombelli

  • 1aDepartment of Health Science, University of Milano-Bicocca bIstituto Auxologico Italiano IRCCS cDepartment of Clinical Sciences and Community Health University of Milano and Fondazione Ospedale Maggiore Policlinico, Milan, Italy dUniversity Clinical Hospital Centre 'Dragisa Misovic', Belgrade, Serbia eIRCCS Multimedica, Sesto San Giovanni, Milan, Italy.

Insights

Left ventricular hypertrophy patterns, particularly concentric LVH, significantly increase cardiovascular and all-cause mortality risk. This new classification system aids in better risk stratification for the general population.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Clinical Epidemiology

Background:

  • Left ventricular geometry is crucial for cardiovascular health.
  • Existing classification systems may not fully capture mortality risk.
  • A new classification system from the Dallas Heart Study offers potential improvements.

Purpose of the Study:

  • To evaluate the association between left ventricular geometric patterns, using a new classification system, and mortality risk.
  • To assess cardiovascular and all-cause mortality in a general population sample.
  • To determine if the new classification system improves risk stratification.

Main Methods:

  • Utilized data from 1716 participants in the Pressioni Monitorate e Loro Associazioni (PAMELA) study.
  • Defined abnormal left ventricular geometric patterns based on left ventricular mass index, diameter, and relative wall thickness.
  • Followed participants for an average of 211 months, collecting death certificate data.

Main Results:

  • Concentric left ventricular hypertrophy (LVH) was associated with a 2.20-fold increased risk of cardiovascular mortality.
  • Eccentric dilated LVH and eccentric nondilated LVH also predicted increased cardiovascular and all-cause mortality.
  • Concentric LVH remained a significant predictor of mortality even after adjusting for left ventricular mass index.

Conclusions:

  • The new classification system for left ventricular geometric patterns enhances mortality risk stratification in the general population.
  • Risk is strongly linked to left ventricular mass, with concentric LVH providing unique prognostic information.
  • This classification system may be valuable for identifying individuals at higher risk of mortality.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
610
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
741
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
463
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
830
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.1K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
552